Skip to main content
idi
Toggle navigation
0
You have 0 notifications
Site Visitor
Site Visitor
New To Inknowvation.com?
Register now to get an access to proprietary SBIR-STTR databases!
Registration is fast and free - start your access to business-actionable information today!
Login
Site Register
SBIR-STTR Award
You are here:
Home
Search Databases
Search SBIR-STTR Awards
SBIR-STTR Award
10
Functional, Hypothesis-Driven, Custom Macroarrays
Award last edited on: 3/22/02
Sponsored Program
SBIR
Awarding Agency
NIH : NHLBI
Total Award Amount
$99,567
Award Phase
1
Solicitation Topic Code
-----
Principal Investigator
Arup Sen
Company Information
Electropharmacology Inc
(
AKA
: Magnetic Resonance Therapeutics, Inc.~Gemini Health Technologies Inc)
12085 Research Drive
Alachua, FL 32615
(904) 462-2249
garykjennings@msn.com
www.geminihealthtech.com
Location:
Single
Congr. District:
03
County:
Alachua
Phase I
Contract Number:
1R43HL065857-01
Start Date:
00/00/00
Completed:
00/00/00
Phase I year
2000
Phase I Amount
$99,567
The long-term goal of the project is to make available different families of species-specific DNA chips carrying the complete spectrum of the genes involved in a functional pathway such as organelle biogenesis or glucose metabolism. The uniqueness of our product will lie in providing extremely affordable and highly focused functional gene arrays. The specific aims of Phase I are to synthesize a customized oligonucleotide- based macroarray for differential gene expression analysis and perform differential gene expression analysis utilizing a biologically relevant model system. It will be possible to use physiological and biological information from well-characterized animal models to examine gene expression in different species and to monitor panels of regulated genes in desired functional pathways in humans utilizing domains of homology. An added novelty of the proposed approach is that oligonucleotides will be selected to minimize the variability between primers on the same array. This technology lends itself to a rapid customization of gene arrays based on an iterative process where oligonucleotides for different genes may be substituted for one another based on the results of analyses of biological specimens. A successful outcome of this approach is likely to lead to custom molecular tools for high throughput assays in drug discovery. PROPOSED COMMERCIAL APPLICATIONS: Validating the use of an oligonucleotide based gene array system will result in a less expensive and customizable way to monitor gene expression of entire gene families and metabolic pathways. The oligonucleotide-based macroarrays will serve as an inexpensive alternative to the sometimes cost prohibitive high-density microarray systems currently available. The low cost will make the macroarrays widely available and thereby accelerate the pace of basic research and drug discovery.
Phase II
Contract Number:
----------
Start Date:
00/00/00
Completed:
00/00/00
Phase II year
----
Phase II Amount
----
×
Login to your account
Mail sent successfully.
Enter any username and password.
Username
Password
Remember me
Login
Forgot your username?
Click here for assistance
Forgot your password?
Request new password
Don't have an account?
Sign up
Forgot username?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.
Forgot password?
Mail sent successfully.
Enter username and password.
Please enter email address that is associated with your account.
Back
Submit
Still Need Help?
If you need further assistance, send us an
e-mail
and we will assist you in resetting your account.